BDX vs FLGT · P/E 34, rev $21.84B vs rev $156.5M
Becton Dickinson and Company (BDX) versus Fulgent Genetics Inc (FLGT) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Fulgent Genetics Inc (FLGT) is a diagnostics & research company listed on US.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported FLGT revenue for 2026-06-30 was $156.5M. Net income was -$54.4M. FLGT currently screens at market cap $586.6M.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. FLGT currently screens at market cap $586.6M.
Not investment advice. Open the BDX and FLGT stock pages for the full models.
Not investment advice.